BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 4639599)

  • 41. Shock: mechanisms and therapy.
    Dietzman RH; Manax WG; Lillehei RC
    Can Anaesth Soc J; 1967 Jul; 14(4):276-86. PubMed ID: 6033503
    [No Abstract]   [Full Text] [Related]  

  • 42. Glucocorticoid therapy in the intensive care unit.
    Loriaux L
    N Engl J Med; 2004 Apr; 350(16):1601-2. PubMed ID: 15084691
    [No Abstract]   [Full Text] [Related]  

  • 43. Use of corticosteroids in the treatment of infectious diseases.
    Krober M
    South Med J; 1974 Jun; 67(6):728-32. PubMed ID: 4597918
    [No Abstract]   [Full Text] [Related]  

  • 44. [Cortisol in critically ill patients with sepsis--physiological functions and therapeutic implications].
    Briegel J
    Wien Klin Wochenschr; 2002; 114 Suppl 1():9-19. PubMed ID: 15503552
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Corticosteroids for patients with septic shock.
    Brown JM
    JAMA; 2003 Jan; 289(1):41; author reply 43-4. PubMed ID: 12503970
    [No Abstract]   [Full Text] [Related]  

  • 46. Corticosteroids for patients with septic shock.
    Zijlstra JG; van der Horst IC; Tulleken JE; van der Werf TS; Ligtenberg JJ
    JAMA; 2003 Jan; 289(1):42; author reply 43-4. PubMed ID: 12503966
    [No Abstract]   [Full Text] [Related]  

  • 47. [Administration of digitalis glycosides in shock].
    Ciesielski L; Bilski D; Rylski J
    Pol Przegl Chir; 1969 Aug; 41(8):1003-7. PubMed ID: 5824757
    [No Abstract]   [Full Text] [Related]  

  • 48. Corticosteroids for patients with septic shock.
    Williamson DR; Albert M; Charneux M
    JAMA; 2003 Jan; 289(1):42; author reply 43-4. PubMed ID: 12503965
    [No Abstract]   [Full Text] [Related]  

  • 49. The effects of ATP and a proteolytic enzyme inhibitor in irreversible shock.
    Massion WH; Erdos EG
    J Okla State Med Assoc; 1966 Aug; 59(8):467-71. PubMed ID: 5296339
    [No Abstract]   [Full Text] [Related]  

  • 50. A new role for glucocorticoids in septic shock: balancing the immune response.
    Bornstein SR; Briegel J
    Am J Respir Crit Care Med; 2003 Feb; 167(4):485-6. PubMed ID: 12588709
    [No Abstract]   [Full Text] [Related]  

  • 51. Adrenal insufficiency occurring during septic shock: incidence, outcome, and relationship to peripheral cytokine levels.
    Soni A; Pepper GM; Wyrwinski PM; Ramirez NE; Simon R; Pina T; Gruenspan H; Vaca CE
    Am J Med; 1995 Mar; 98(3):266-71. PubMed ID: 7872343
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Does the reduced glutathione have a beneficial effect on shock? (author's transl)].
    Ogawa R; Miygawa E; Fujita T
    Masui; 1978 Oct; 27(10):1054-8. PubMed ID: 702783
    [No Abstract]   [Full Text] [Related]  

  • 53. Relative adrenal insufficiency as a predictor of disease severity, mortality, and beneficial effects of corticosteroid treatment in septic shock.
    de Jong MF; Beishuizen A; Spijkstra JJ; Groeneveld AB
    Crit Care Med; 2007 Aug; 35(8):1896-903. PubMed ID: 17568326
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Endorphins in shock and spinal injury; therapeutic effects of naloxone and thyrotropin-releasing hormone.
    Holaday JW
    Prog Clin Biol Res; 1983; 111():167-84. PubMed ID: 6306678
    [No Abstract]   [Full Text] [Related]  

  • 55. [Mediators in shock processes: pathogenetic and therapeutic problems].
    Habermann E
    Verh Dtsch Ges Inn Med; 1971; 77():1221-9. PubMed ID: 4346177
    [No Abstract]   [Full Text] [Related]  

  • 56. Influence of choline on the reticuloendothelial system and on survival after experimental shock.
    Altura BM; Hersey SG; Hyman C
    J Reticuloendothel Soc; 1966 May; 3(1):57-64. PubMed ID: 5962374
    [No Abstract]   [Full Text] [Related]  

  • 57. Shock lung.
    Hardaway RM
    Int Surg; 1973 May; 58(5):308-10. PubMed ID: 4512931
    [No Abstract]   [Full Text] [Related]  

  • 58. Beneficial effects of erythropoietin in preclinical models of shock and organ failure.
    Thiemermann C
    Crit Care; 2007; 11(3):132. PubMed ID: 17543134
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Current concepts in physiopathology and the management of "shock"].
    De Roni EA; Navia JA; Montrul M; Invierno J; Rossi C; Esandi F; Echeverria H
    Prensa Med Argent; 1968 May; 55(14):628-38. PubMed ID: 5720923
    [No Abstract]   [Full Text] [Related]  

  • 60. Use of glucocorticoids in shock.
    Yamamura H; Kosugi I; Okada K
    Prog Clin Biol Res; 1983; 111():229-41. PubMed ID: 6346329
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.